2009 annual financial data
Halozyme Therapeutics 2009 Net margin
Direct answer
Net margin was -426.88%.
Operating income was -58,458,260 USD and net income was -58,360,523 USD.
Operating cash flow was -40,148,265 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,671,305 USD
- Operating income
- -58,458,260 USD
- Net income
- -58,360,523 USD
- Operating cash flow
- -40,148,265 USD
Explore related company data
View all 2009 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Halozyme Therapeutics financial years